| First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE … HS Wasan, P Gibbs, NK Sharma, J Taieb, V Heinemann, J Ricke, ... The Lancet Oncology 18 (9), 1159-1171, 2017 | 372 | 2017 |
| The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors JR Strosberg, TR Halfdanarson, AM Bellizzi, JA Chan, JS Dillon, ... Pancreas 46 (6), 707-714, 2017 | 293 | 2017 |
| PTEN mutations are common in sporadic microsatellite stable colorectal cancer NT Nassif, GP Lobo, X Wu, CJA Henderson, CD Morrison, C Eng, ... Oncogene 23 (2), 617-628, 2004 | 193 | 2004 |
| Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial RS Kerr, S Love, E Segelov, E Johnstone, B Falcon, P Hewett, A Weaver, ... The Lancet Oncology 17 (11), 1543-1557, 2016 | 166 | 2016 |
| Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer DLH Chan, E Segelov, RSH Wong, A Smith, RA Herbertson, BT Li, ... Cochrane Database of Systematic Reviews, 2017 | 115 | 2017 |
| International rare cancers initiative multicenter randomized phase II trial of cisplatin and fluorouracil versus carboplatin and paclitaxel in advanced anal cancer: InterAAct S Rao, F Sclafani, C Eng, RA Adams, MG Guren, D Sebag-Montefiore, ... Journal of Clinical Oncology 38 (22), 2510, 2020 | 108 | 2020 |
| Diagnosis and management of gastrointestinal neuroendocrine tumors: an evidence-based Canadian consensus S Singh, SL Asa, C Dey, H Kennecke, D Laidley, C Law, T Asmis, D Chan, ... Cancer Treatment Reviews 47, 32-45, 2016 | 107 | 2016 |
| Management of advanced gastric cancer TJ Price, JD Shapiro, E Segelov, CS Karapetis, N Pavlakis, E Van Cutsem, ... Expert review of gastroenterology & hepatology 6 (2), 199-209, 2012 | 103 | 2012 |
| The aetiological role of human papillomavirus in oesophageal squamous cell carcinoma: a meta-analysis SS Liyanage, B Rahman, I Ridda, AT Newall, SN Tabrizi, SM Garland, ... PLoS One 8 (7), e69238, 2013 | 90 | 2013 |
| Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. E Segelov, J Campbell, M Ng, M Tattersall, R Rome, K Free, N Hacker, ... Journal of clinical oncology 12 (2), 378-384, 1994 | 89 | 1994 |
| Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors S Singh, L Moody, DL Chan, DC Metz, J Strosberg, T Asmis, DL Bailey, ... JAMA oncology 4 (11), 1597-1604, 2018 | 85 | 2018 |
| Effect of fractional carbon dioxide laser vs sham treatment on symptom severity in women with postmenopausal vaginal symptoms: a randomized clinical trial FG Li, S Maheux-Lacroix, R Deans, E Nesbitt-Hawes, A Budden, ... Jama 326 (14), 1381-1389, 2021 | 84 | 2021 |
| Commonwealth neuroendocrine tumour research collaboration and the North American neuroendocrine tumor society guidelines for the diagnosis and management of patients with lung … S Singh, EK Bergsland, CM Card, TA Hope, PL Kunz, DT Laidley, ... Journal of Thoracic Oncology 15 (10), 1577-1598, 2020 | 76 | 2020 |
| Physical activity and fitness in women with metastatic breast cancer J Yee, GM Davis, JM Beith, N Wilcken, D Currow, J Emery, J Phillips, ... Journal of Cancer Survivorship 8, 647-656, 2014 | 76 | 2014 |
| Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue CX Sandler, D Goldstein, S Horsfield, BK Bennett, M Friedlander, ... Journal of Pain and Symptom Management 54 (1), 74-84, 2017 | 71 | 2017 |
| Effect of primary tumor side on survival outcomes in untreated patients with metastatic colorectal cancer when selective internal radiation therapy is added to chemotherapy … P Gibbs, V Heinemann, NK Sharma, J Taieb, J Ricke, M Peeters, ... Clinical colorectal cancer 17 (4), e617-e629, 2018 | 67 | 2018 |
| Practical considerations for treating patients with cancer in the COVID-19 pandemic E Segelov, C Underhill, H Prenen, C Karapetis, C Jackson, L Nott, T Clay, ... JCO Oncology Practice 16 (8), 467-482, 2020 | 66 | 2020 |
| Recurrence in resected gastroenteropancreatic neuroendocrine tumors S Singh, DL Chan, L Moody, N Liu, HD Fischer, PC Austin, E Segelov JAMA oncology 4 (4), 583-585, 2018 | 64 | 2018 |
| Response to cetuximab with or without irinotecan in patients with refractory metastatic colorectal cancer harboring the KRAS G13D mutation: Australasian Gastro-Intestinal … E Segelov, S Thavaneswaran, PM Waring, J Desai, KP Robledo, ... Journal of Clinical Oncology 34 (19), 2258-2264, 2016 | 55 | 2016 |
| Targeted therapy for metastatic colorectal cancer TJ Price, M Tang, P Gibbs, DG Haller, M Peeters, D Arnold, E Segelov, ... Expert review of anticancer therapy 18 (10), 991-1006, 2018 | 53 | 2018 |
Timothy PriceThe Queen Elizabeth Hospital and School of Medicine University of AdelaideVerified email at adelaide.edu.au
